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To study the role of silent ischemia and the arrhythmic 
substrate in the genesis of sudden cardiac death, 67 patients 
were studied (mean age 62 f 12 years). Of these, 14 
patients (Group 1) had an in-hospital episode of ventricular 
tachycardia or fibrillation while wearing a 24 h Halter 
ambulatory electrocardiographic (ECG) monitor, 33 
(Group II) had a documented episode of sustained ventric- 
ular tachycardia or fibrillation, or both, and 20 (Group III) 
had angina pectoris but no ventricular tachycardia or 
fibrillation. Eight Group I survivors underwent pro- 
grammed electrical stimulation or ECG signal averaging, 
or both. All Group II patients underwent 24 h Halter 
monitoring and ECG signal averaging to detect late poten- 
tials before programmed electrical stimulation. Group III 
patients underwent both 24 h Holter recording and coro- 
nary angiography. The 24 h ECG tapes were analyzed for 
ST segment changes, prematurity index and characteristics 
of ventricular premature depolarizations. Any ST depres- 
sion rl mm for >30 s was considered to be a reflection of 
silent ischemia, and the induction of ventricular tachycar- 
dia or fibrillation by programmed electrical stimulation or 
the presence of late potentials, or both, was considered to 
be a reflection of the arrhythmia substrate. 
Silent ischemia preceded ventricular tachycardia in only 
2 (14%) of the 14 Group I patients. The prematurity index 
was <l in only 18% of ventricular tachycardia episodes. 
However, 14 (64%) of 22 episodes of ventricular tachycar- 
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dia in 9 (64%) of the 14 patients were initiated by a 
ventricular premature depolarization preceded by a short- 
long sequence (sinus beat-ventricular premature depolar- 
ization-sinus beat) with a ratio of 0.5 f 0.1. Six (75%) of 
eight in-hospital survivors of ventricular tachycardia or 
fibrillation (Group I) had an arrhythmic substrate. A 
significantly (p < 0.0001) higher percent of the 33 Group II 
patients had an arrhythmic substrate (93%) than had silent 
ischemic episodes (45%). Silent ischemia resulted in ven- 
tricular tachycardia in only 1(7%) of 15 Group II patients. 
There was no significant difference between the incidence of 
silent ischemia (45% versus 35%) and the extent of coro- 
nary artery disease between Groups II and III. 
It is concluded that: 1) Silent ischemia was not a major 
determinant of ventricular tachycardia. 2) Although silent 
ischemia was common in survivors of ventricular tachycar- 
dia or fibrillation, its incidence was not significantly dif- 
ferent from that in patients with angina pectoris and no 
sustained ventricular arrhythmias. 3) A high percent of 
patients (75% to 93%) with ventricular tachycardia and 
fibrillation have an arrhythmic substrate. 4) In the absence 
of acute myocardial infarction, sudden cardiac death is 
frequently triggered by a ventricular premature depolar- 
ization, with a preceding short-long cycle that likely pro- 
duces dispersion of refractoriness in the arrhythmic sub- 
strate. 
(J Am Co11 Cardiol1989;14:1618-25) 
Sudden cardiac death is a major health problem in the United 
States, claiming approximately 450,000 lives each year. 
Out-of-hospital resuscitation studies (l-4) have shown that 
the rhythm disturbance resulting in sudden cardiac death is 
usually ventricular tachycardia that degenerates into ventric- 
ular fibrillation. Although most patients with sudden cardiac 
death have coronary artery disease, the majority do not have 
a history of chest pain before collapse (5). Thus, circumstan- 
tial evidence points to silent myocardial ischemia as a 
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potentially important causative factor in the genesis of 
sudden cardiac death. It has also been demonstrated (6-9) 
that the majority of patients with sudden cardiac death have 
inducible ventricular tachyarrhythmias, pointing to the ar- 
rhythmic substrate as an important determinant of ventricu- 
lar tachycardia and fibrillation. However, the specific roles 
of silent ischemia and the arrhythmic substrate and their 
interaction have not been appropriately defined. The pur- 
pose of this study was to address this issue. 
Methods 
Study patients. A total of 67 patients (mean age 62 ‘-c 12 
years) were studied. The patients had a history and electro- 
cardiographic (ECG) or angiographic evidence, or both, of 
coronary artery disease. To satisfy the objectives of the 
study, the following three groups of patients with different 
clinical presentations were selected. Group I comprised 14 
patients who had in-hospital ventricular tachycardia and 
fibrillation while wearing a 24 h ambulatory ECG (Holter) 
monitor. Five of these patients were receiving an antiar- 
rhythmic agent (procainamide in three and quinidine in two); 
however, none had QT prolongation (20.44 s) or evidence of 
drug toxicity or hypokalemia within 24 h of the episode. 
Group II comprised 33 patients who had a documented 
episode of sustained ventricular tachycardia (17 patients) 
and ventricular fibrillation (16 patients) and were referred for 
electrophysiologic studies. Group I11 comprised 20 patients 
with angina pectoris (13 unstable and 7 stable). None of 
these patients had a history of ventricular tachycardia or 
fibrillation and all were referred for cardiac catheterization. 
The exclusion criteria for all three groups included: I) ~1 
mm baseline ST depression on Holter monitoring: hypokale- 
mia, and 3) antiarrhythmic drug toxicity (Group I) as well as 
antiarrhythmic drug therapy (Groups II and III). 
All 67 patients had 24 h Holter monitoring utilizing the 
Marquette 8500 two channel recorder and an 8000 playback 
analysis system with a frequency response of 0.05 to 60 Hz. 
Only 5 of the I4 Group 1 patients and none of the Group II 
and 111 patients were receiving antiarrhythmic drug therapy 
during the 24 h Holter monitoring. In Group I, the Holter 
tapes were analyzed for ST segment depression preceding 
ventricular tachyarrhythmias, as well as heart rate changes 
and characteristics of ventricular premature depolarization 
preceding ventricular tachycardia and fibrillation. Eight and 
seven patients from Group I underwent programmed ven- 
tricular stimulation and ECG signal averaging, respectively. 
Group II patients additionally underwent ECG signal 
averaging of the surface QRS complex performed with 
commercially available systems (Arrhythmia Research 
Technology and Corazonix Corporation), coronary angiog- 
raphy and programmed electrical stimulation. The latter was 
performed according to a standard protocol that consisted of 
up to three extrastimuli at two basic pacing drives (600 and 
450 ms) and burst ventricular pacing at the apex and outflow 
tract of the right ventricle. Isoproterenol and left ventricular 
stimulation were not used in any of Group II patients. All 
Group III patients had coronary angiography in addition to 
24 h Holter monitoring. 
Validation of the Holter system for ST segment changes. 
To validate the Holter monitoring system for determining ST 
segment changes, an additional 20 patients had an exercise 
test and simultaneous Holter ECG monitoring. The exercise 
test was done using the Marquette Case 12 treadmill with 
automatic 12 lead ECG recording. The stress ECG and 
Holter ECG were considered positive if 2 1 mm horizontal or 
downsloping ST depression, or both, was present 80 ms after 
the J point. There were 10 episodes of significant ST depres- 
sion by either method; 8 of the 10 episodes were detected on 
the Holter ECG and 9 of the 10 on the 12 lead ECG. Con- 
cordant results between the Holter and stress ECG monitor- 
ing were obtained in 17 (85%) of the 20 patients. An excellent 
correlation (r = 0.95) was also noted between the computer 
readouts for the magnitude of ST changes and manual 
readouts. 
Definition of terms. Silent ischemia. This was defined as 
painless ST segment depression rl mm 80 ms after the J 
point and lasting for 230 s. The ST segment changes were 
determined by computer, and the ischemic episodes by two 
of the senior investigators who read the real time printouts 
without knowledge of each other’s findings. 
Arrhrthmic substrute. An arrhythmic substrate was con- 
sidered present on the basis of 1) inducibility of ventricular 
tachycardia or ventricular fibrillation, or 2) an abnormal 
signal-averaged ECG, or both I and 2. An abnormal signal- 
averaged ECG was defined if the root mean square voltage of 
the terminal 40 ms was ~20 WV, the duration of low 
amplitude signals of ~40 /_LV was >38 ms, the duration of the 
signal-averaged QRS complex was > 114 ms at 40 Hz high 
pass filtering in the absence of bundle branch block or 
combinations of these variables (10). 
Prrmuturit~ index. This index was the coupling interval 
of the ventricular premature depolarization initiating ventric- 
ular tachycardia divided by the QT interval. 
Statistics. All data represent mean values + SD. Statis- 
tical analysis was performed with the Student’s t test and 
chi-square analysis where appropriate. 
Results 
Group I 
Ventricular tachycardia or fibrillation. There were 22 
episodes of ventricular tachycardia, of which 12 were sus- 
tained and 10 were nonsustained. The 10 episodes of non- 
sustained ventricular tachycardia lasted for 37 ? 23 beats 
(range I5 to 90) and terminated spontaneously. Nine of the 
22 episodes were monomorphic and 13 episodes were poly- 
morphic or of the “torsade de pointes” type. Ventricular 
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Figure 1. Holter monitor electrocardiographic (ECG) recordings 
showing the initiation of polymorphic ventricular tachycardia (C) 
during a silent ischemic episode (ST depression 4 to 7 mm). For 
further explanation, see test. HR = heart rate; MR = mitral 
regurgitation; PI = prematurity index. 
tachycardia degenerated into ventricular fibrillation in 7 of 
the 14 patients. Only 2 (14%) of the 14 patients manifested 
silent ischemia before ventricular tachycardia, for a total of 
6 (27%) of the 22 episodes. In one of the two patients (Fig. 
IC), significant horizontal and downsloping ST segment 
depression of -7 to -4 mm occurred before ventricular 
tachycardia. The ventricular tachycardia that was polymor- 
phic in configuration was initiated by a late-coupled ventric- 
ular premature depolarization with a prematurity index of 
1.7 and was preceded by a sinus beat-ventricular premature 
depolarization-sinus beat sequence and a short-long interval 
with a ratio of 0.42. 
Heart rate preceding ventricular tachycardia. The heart 
rate just preceding ventricular tachycardia was significantly 
faster than the minimal heart rate (79 + 15 versus 56 ? 16 
beats/min, p < 0.001) for the duration of Holter monitoring; 
however, it was not significantly different from the average 
heart rate (79 ? 15 versus 81 5 8 beats/min). The maximal 
heart rate for the monitoring period was significantly faster 
than the heart rate just preceding ventricular tachycardia 
(120 ? 20 versus 79 2 15 beats/min). The prematurity index 
of the ventricular premature depolarization initiating ventric- 
ular tachycardia was <l in only 18% of the 22 episodes of 
ventricular tachycardia. 
Short-long cycle preceding ventricular tachycardia. In 9 
(64%) of the 14 Group I patients for a total of 14 (64%) of the 
22 episodes of ventricular tachycardia, ventricular tachycar- 
dia was preceded by a short-long cycle that consisted of a 
sinus beat followed by a ventricular premature depolariza- 
tion (short cycle) and a pause followed by another sinus beat 
(long cycle). The short-long sequence had a mean ratio of 
0.5 t 0.1. Of the 14 ventricular tachycardia episodes that 
were preceded by a short-long cycle, 9 (64%) were polymor- 
phic. An example of this phenomenon is illustrated in Figure 
2 from a patient who had ventricular tachycardia that degen- 
erated into ventricular fibrillation 10 days after inferior wall 
myocardial infarction. The patient was not taking antiar- 
rhythmic or beta-adrenergic blocker therapy before the 
episodes of in-hospital ventricular tachycardia and fibrilla- 
tion. At 8:57:07, a ventricular premature depolarization with 
a premature index of 0.9 initiated a run of nonsustained 
ventricular tachycardia. At 9:53:07, a ventricular premature 
A. Figure 2. Holter monitor ECG recordings 
showing the initiation of ventricular tachy- 
cardia that degenerates into ventricular fi- 
brillation after a short-long sequence. For 
further explanation, see text. Abbreviations 
as in Figure 1. 
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MW 
JACC Vol. 14, No. 7 GOMES ET AL. 1621 
December 1989: 161%!i SILENT ISCHEMIA AND AKKHYTHMIC SUBSTRATE IN SUDDEN DEATH 
Table 1. Halter Electrocardiographic Findings in Groups II 
and III -~ 
Group II Group 111 p Value 
______ 14:a:ss ST:-4+nm 
SI IS of 33 (45%) 7 of 20 (3%) NS HR=94 c Omm 
Arrhythmic substrate 3 I of 33 (93%) - 
SI before VT I of 15 (7%) 0 IO%) NS 
Max ST depressIon (mm) 2.93 ? 1.58 I.7 + 7 -_ NS 
No. of episodes of Sl 3.86 i 2.66 4.1 t 3 NS 
Group II = patienrs with ventricular tachycardia or ventricular fibrillation; 
Group III = patient5 without ventricular tachycardia or fibrillation: Max = 
maximal: SI = silent irchemia: VT = ventricular tachycardia. 
depolarization with a premature index of 0.8 resulted in a 
couplet. At 9:53:24. a ventricular premature depolarization 
with a premature index of 1 and a configuration similar to 
that noted previously resulted in a rapid ventricular tachy- 
cardia (300 beatsimin) that degenerated into ventricular 
fibrillation in approximately 4 min. Note that the onset of 
ventricular tachycardia is preceded by a short-long cycle Figure 3. Hotter monitor ECG recordings showing silent ischemia 
(sinus beat-ventricular premature depolarization-sinus beat) 
and nonsustained ventricular tachycardia in the absence of silent 
with a ratio of 0.4. Also note that, when nonsustained 
ischemia in a patient in Group II. At 14:21:55 (top), the patient has 
a sinus rate of 94 beatsimin and ST deoression of 4.9 mm. During the 
ventricular tachycardia and couplets occurred, these were next episode of silent ischemia. there were no ventricular arrh;th- 
not preceded by a short-long cycle. 
substrate was present in six (75%) of the eight patients. 
Eight of 14 patients who survived underwent follow-up 
programmed electrical stimulation, and 7 had ECG signal 
averaging of the surface QRS complex. An arrhythmic 
tachycardia by programmed electrical stimulation. HR = heart rate. 
mias. At 19:53:06 (bottom). the heart rate is 72 beatsimin and there 
is no significant ST depression. A run of nonsustained (seven beat) 
ventricular tachycardia at a rate of 170 beatsimin is initiated by a late 
coupled ventricular premature depolarization. The patient had an 
arrhythmic substrate with the induction of a similar ventricular 
Silent &hernia (Table 1). Silent ischemic episodes oc- 
curred in 15 (45%) of the 33 Group II patients and in 7 (35%) 
of the 20 Group III patients (p = NS). There was no 
significant difference between the two groups in the number 
of episodes of silent ischemia or the maximal ST depression 
during silent ischemia. Of the 15 Group II patients with silent 
ischemic episodes, sustained ventricular tachycardia was 
noted on the Holter monitor in only 1 patient (7%;) and was 
preceded by ST segment depression of I to I .5 mm. None of 
the remaining 14 patients had sustained or nonsustained 
ventricular rachycardia during or after the episodes of silent 
ischemia (Fig. 31. 
Arrhythmic substrate (Table 1). Thirty-one (93%) of 33 
patients in Group II had an arrhythmic substrate. Thus, a 
significantly higher number of patients in this group had an 
arrhythmic substrate than had silent ischemic episodes (93% 
versus 45%. respectively, p < 0.0001). Figure 4 is an 
example from the single patient who had a silent ischemic 
episode before a spontaneous episode of ventricular tachy- 
cardia on the Holter monitor. The patient had severe triple 
vessel coronary artery disease and an old inferolateral 
myocardial infarction. The signal-averaged ECG revealed 
the presence of late potentials. The patient also had induc- 
ible rapid monomorphic ventricular tachycardia with the use 
of double extrastimuli during programmed ventricular stim- 
ulation. 
Coronary angiography and left ventriculography (Table 2). 
There was no significant difference in the incidence of triple, 
double or single vessel disease between Groups II and III; 
however, a significantly higher number of patients in Group 
II had a left ventricular aneurysm. 
Discussion 
Analysis of silent iscbemia and arrbythmic substrate in the 
genesis of sudden cardiac death. In this study, we assessed 
the role of silent myocardial ischemia and the arrhythmic 
substrate in the genesis of sudden cardiac death due to 
ventricular tachycardia and fibrillation. Silent ischemic epi- 
sodes were assessed on a Holter ECG monitor utilizing 
appropriate frequency response (1 l-13) and validation stud- 
ies for ST segment analysis. Although some controversy 
exists regarding the significance of ST changes on Holter 
monitoring several previous studies (14-23) have amply 
documented the validity of Holter ST segment analysis for 
the assessment of silent ischemia. To test whether silent 
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Figure 4. Signal-averaged ECG (panel A) and pro- 
grammed electrical stimulation (panel B) in the only 
patient from Group II who also had silent ischemia 
before spontaneous ventricular tachycardia on 24 h 
Holter recording. In panel A, the vector magnitude of 
the signal-averaged ECG shows late potentials. Note 
that all quantitative variables, namely, the duration of 
the vector magnitude (163 ms), root mean square (RMS) 
voltage (5 pV) and duration of low amplitude signals 
(LAS) of 92 ms, are abnormal. In panel B, programmed 
electrical stimulation with the use of two extrastimuli 
(300 and 280 ms) at a basic cycle length of 600 ms 
induced sustained rapid monomorphic ventricular 
tachycardia similar in configuration to the spontaneous 
tachycardia. For further explanation, see text. R = rate. 
ischemia or the arrhythmic substrate, or both, was the major 
determinant of sudden cardiac death, we studied three 
groups of patients. 
From Group I, information was obtained regarding the 
electrical and ischemic behavior of the ventricular myocar- 
dium before ventricular tachycardia and fibrillation; from 
Group II, information was derived regarding the incidence of 
silent ischemia, its relation to the development of spontane- 
ous ventricular tachycardia or fibrillation and the presence of 
an arrhythmic substrate. The presence of an arrhythmic 
substrate was defined on the basis of inducible ventricular 
tachycardia or fibrillation by using standard stimulation 
protocols in the laboratory, as well as ECG signal processing 
techniques to assess the presence of late potentials. An 
abnormal signal-averaged ECG has been amply shown 
(24-26) to reflect delayed and inhomogeneous propagation of 
electrical activity in scarred myocardium. Information ob- 
tained from Group III served as control information for 
Group II patients regarding the incidence of silent ischemic 
episodes, as well as coronary anatomy and left ventricular 
geometry. It was hypothesized that this analysis in the three 
groups of patients would provide a clearer understanding of 
Table 2. Coronary Anatomy on Angiography in Groups II and III 
Three Vessel Two Vessel One Vessel 
Disease Disease Disease LV Aneurysm 
Group II 12 of 33 (36%) 1 I of 33 (33%) 10 of 33 (30%) 14 of 33 (42%) 
Group III 10 of 20 (50%) 7 of 20 (35%) 3 of 20 (15%) 1 of 20 (5%) 
p value NS NS NS 0.01 
Group II = patients with ventricular tachycardia or ventricular fibrillation; Group III = patients without 
ventricular tachvcardia or fibrillation. LV = left ventricular. 
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the role of silent &hernia and the arrhythmic substrate in the 
genesis of sudden cardiac death. 
Role of silent ischemia in the genesis of ventricular tachy- 
cardia and fibrillation. Our results suggest that silent isch- 
emia was not a major determinant of ventricular tachycardia 
and fibrillation. Indeed, silent ischemic episodes preceded 
ventricular tachycardia in only 2 of 14 patients who had 
ventricular tachycardia or fibrillation, or both, on a Holter 
monitor recording (Group 1). Although silent ischemic epi- 
sodes were common (45%) in patients with documented 
ventricular tachycardia or fibrillation (Group II), in only one 
patient (7%) did silent ischemia precede ventricular tachy- 
cardia. However. this patient also had an arrhythmic sub- 
strate as suggested by inducibility of sustained ventricular 
tachycardia and late potentials on the signal-averaged ECG. 
Furthermore, the incidence of triple, double and single 
vessel coronary artery disease was not significantly different 
in patients with ventricular tachycardia or fibrillation. or 
both (Group II) from that in patients with symptomatic 
coronary artery disease and no history of sustained ventric- 
ular arrhythmias. Thus. observations in Group II and III 
patients suggest that the high incidence of silent ischemia 
seen in patients with sustained ventricular arrhythmias is a 
reflection of its prevalence in patients with coronary artery 
disease in general and is not specific to patients with sus- 
tained ventricular arrhythmias. Several previous studies 
(18.21.22) noted a high prevalence of silent ischemic epi- 
sodes in patients with stable and unstable angina pectoris. 
A few isolated reports (27-30) clearly noted an associa- 
tion between painless myocardial ischemia during exercise 
testing or Holter ECG monitoring and the initiation of 
ventricular tachycardia and fibrillation. Sharma et al. (27) 
demonstrated silent myocardial ischemia and wall motion 
abnormalities by means of exercise testing in 12 of IS 
patients who had survived an out-of-hospital cardiac arrest. 
Six of their patients demonstrated episodes of ventricular 
tachycardia on 24 h Holter monitoring and 11 had frequent 
ventricular premature depolarizations (>30/h). However, in 
their study, Sharma et al. did not analyze ST segment 
depression preceding episodes of ventricular tachycardia on 
Holter recording or determinants of the presence of an 
arrhythmic substrate. Thus. it is highly likely that the 
demonstration of silent ischemic episodes on exercise testing 
in their patients merely reflected the prevalence of such 
episodes in patients with coronary artery disease, as dem- 
onstrated in our study. Although acute myocardial infarction 
and significant painful and painless myocardial ischemia may 
result in sustained ventricular tachyarrhythmias. the tran- 
sient and painless ischemic episodes generally described by 
the term “silent ischemia” are not specific triggers for 
sustained ventricular arrhythmias. In fact. most patients 
with these malignant arrhythmias do not show silent isch- 
emit episodes before the occurrence of ventricular tachycar- 
dia or fibrillation. 
Role of the arrhythmic substrate in the genesis of sudden 
cardiac death. Our results suggest that the majority of 
patients with sustained ventricular tachyarrhythmias (Group 
II) have an arrhythmic substrate, as evidenced by the 
presence of late potentials on the signal-averaged ECG or 
inducible ventricular tachycardia and fibrillation on pro- 
grammed ventricular stimulation, or both. These findings are 
in agreement with previous studies (5-8) in survivors of 
out-of-hospital sudden cardiac death and point to the ar- 
rhythmic substrate as an important determinant of ventricu- 
lar tachyarrhythmias. Furthermore, the arrhythmic hypoth- 
esis is favored over the ischemic hypothesis in our patients 
by the observations of a significantly higher incidence of left 
ventricular aneurysm and lack of appreciable differences in 
the extent and degree of coronary artery disease in patients 
in our Group II (sustained ventricular tachyarrhythmias) 
v+;hen compared with patients in our Group III (no sustained 
ventricular tachyarrhythmias). 
The trigger for ventricular tachycardia and fibrillation: the 
short-long sequence. Our results suggest that ventricular 
tachycardia is often triggered by a ventricular premature 
depolarization with a preceding short-long cycle. The short 
cycle comprises a sinus beat followed by a ventricular 
premature depolarization, and the long cycle comprises the 
ventricular premature depolarization followed by a sinus 
beat. The long cycle is approximately twice that of the short 
cycle. Kay et al. (31) noted that a “long-short” initiating 
sequence triggered torsade de pointes in 41 of 44 episodes 
associated nith antiarrhythmic drug toxicity and baseline 
prolongation of the QT interval and hypokalemia or hypo- 
magnesemia alone or in combination. However. a review of 
their published ECG examples demonstrates that their 
“long-short sequence” is indeed a “short-long cycle” pre- 
ceding the ventricular premature depolarization that trig- 
gered the torsade de pointes. Thus. our findings suggest that 
a short-long cycle often but not always. serves as a trigger 
for ventricular tachycardia even in the absence of antiar- 
rhythmic drug toxicity alone or in association with electro- 
lyte abnormalities. It is of additional interest that nearly 
twice as many episodes of ventricular tachycardia that were 
initiated by a ventricular premature depolarization with a 
short-long sequence were polymorphic or torsade de pointes 
type, whereas monomorphic ventricular tachycardia was 
less often initiated by a short-long sequence. The underlying 
mechanism for this phenomenon is unclear: however, the 
following hypotheses are offered. 
I) It is possible that the short-long sequence preceding the 
ventricular premature depolarization initiating ventricular 
tachycardia produces dispersion of refractoriness in the 
arrhythmic substrate. Additionally. it is possible that a larger 
mass of Purkinje muscle fibers achieves critical conduction 
delays and blocks favoring a sustained reentrant tachycar- 
dia. A similar mechanism could likewise activate multiple 
circuits. resulting in polymorphic ventricular tachycardia 
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and fibrillation. Divergence between refractoriness of the 
His-Purkinje system and ventricular myocardium was dem- 
onstrated after programmed ventricular stimulation by Den- 
ker et al. (32), using a short-long pacing protocol. These 
investigators (33) also demonstrated induction of ventricular 
tachycardia in the electrophysiology laboratory by utilizing a 
pacing protocol that incorporated a short-long sequence in 
the absence of antiarrhythmic drugs. 
2) An alternative mechanism for the initiation of ventric- 
ular tachycardia after the short-long cycle is early afterde- 
polarizations (34-36). Because of the compensatory pause 
after the ventricular premature depolarization, the next sinus 
impulse could result in repolarization abnormalities that 
trigger repetitive activity. The lack of QTu prolongation in 
the postextrasystolic sinus beat may be related to early 
afterdepolarizations arising in a small arrhythmic focus, as 
suggested by Cranefield and Aronson (36). 
3) It is possible that both of the mechanisms just men- 
tioned play a role in the genesis of ventricular tachycardia 
initiated by a preceding short-long cycle. Shortening of 
muscle refractoriness (32) in the arrhythmic substrate after 
the short-long cycle could enable penetration of the arrhyth- 
mic substrate by ventricular depolarizations due to early 
afterdepolarization after the long cycle, triggering a reen- 
trant ventricular tachycardia, as previously discussed. 
Our study showed that prematurity of ventricular prema- 
ture depolarizations was not a trigger for ventricular tachy- 
cardia in the majority of patients because a ventricular 
premature depolarization with a prematurity index <I in- 
duced only 18% of the ventricular tachycardia episodes. The 
lack of a significant increase in heart rate before ventricular 
tachycardia or fibrillation over that of the mean heart rate 
suggests a lack of significant increase in sympathetic tone as 
one of the trigger factors for ventricular tachycardia. These 
observations are in accordance with previous findings 
(37,38) from Holter recordings during ventricular tachycar- 
dia and fibrillation. However, recent studies (39-41) have 
shown that decreased heart rate variability appears to char- 
acterize the risk for sudden cardiac death in the canine 
infarct model and in human patients. 
Limitations of the study. 1) In this study, the presence of 
an arrhythmic substrate was not tested in all Group 1 and 
Group III patients. However, this was not possible in those 
patients from Group I who did not survive the episode of 
ventricular fibrillation. Group III patients had no history of 
ventricular tachyarrhythmia and were primarily used as 
control subjects for Group II patients to assess the relative 
incidence of silent ischemia in the two groups. 2) The 
occurrence of monomorphic and polymorphic ventricular 
tachycardia was based on the configuration of the QRS 
complex on the two channel Holter recorder. It is possible 
that if multiple leads had been obtained, some monomorphic 
ventricular tachycardias might have been classified as poly- 
morphic. However, this limitation cannot be overcome in a 
Holter ECG study. 
Implications. The following implications may be drawn 
from this study. 1) Silent myocardial ischemia was not a 
major determinant of ventricular tachycardia or fibrillation in 
this group of patients. Nevertheless, the observation of 
frequent silent ischemic episodes in patients with ventricular 
tachycardia and fibrillation lends credence to the use of 
anti-ischemic agents in these patients. Therapy, however, 
should be focused on the arrhythmic substrate in those 
patients with sustained ventricular tachyarrhythmias who 
reveal electrophysiologic characteristics of the latter. 2) Be- 
cause this is a select group of patients, the majority of whom 
survived the episode of ventricular tachycardia and fibrilla- 
tion and were referred to electrophysiologic study, our 
observations should not be applied to the entire spectrum of 
patients with sudden cardiac death. 3) Pacing algorithms to 
prevent the short-long sequence by aborting the long se- 
quence after a ventricular premature depolarization may 
indeed be a preventive measure that can be incorporated in 
pacemakers as well as in the automatic cardioverter- 
defibrillator. 
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